Alkem Laboratories is a leading pharmaceutical company with over 23 manufacturing facilities in India and the United States of America. For over 50 years, Alkem has focused their 500 scientists working across five R&D centers on innovations aligned with the pursuit of “Extended Lifecare Beyond Boundaries.”
But the very nature of their work makes Alkem Laboratories a target for cyber criminals who are eager to get ahold of their research data and intellectual property (IP). In fact, in 2022 the healthcare industry was the most targeted in India, with healthcare organizations experiencing 1,866 attacks per week, on average. And unfortunately the attacks haven’t stopped in 2023.
Eager to proactively protect themselves against the growing wave of cyber threats, Alkem Laboratories partnered with Check Point to enhance its security infrastructure. Alkem implemented Check Point Quantum Security Gateways in the data center, disaster recovery, and development centers. Quantum provides Alkem Laboratories threat prevention capabilities against zero-day threats and other advanced malicious activities across its network, cloud infrastructure, data center, and remote environments.
Recognizing that over 90% of cyberattacks on organizations originate from malicious emails, Alkem also deployed Check Point Harmony Email to protect their employees’ inboxes. As a result, Alkem observed a significant reduction in phishing emails – from 50 daily reports to zero.
The result? According to Bijender Mishra, Chief Information Security Officer at Alkem Laboratories, “Check Point provides us peace of mind, knowing that we have the best security solution safeguarding Alkem.”
To learn more about how Alkem Laboratories is preventing disruptions to their pharmaceutical operations, visit https://www.checkpoint.com/customer-stories/alkem-laboratories/